Analyst Ratings for Climb Bio (CLYM)
CLYM Rating Summary
CLYM Price Target Summary
- Highest: $23.00 (Piper Sandler)
- Lowest: $8.00 (BTIG)
- Average: $12.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.67 (+76.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Wedbush | Laura Chico | New Coverage | Outperform (N/A) |
12.00 (N/A) |
7.28 (7.18) |
-1.37% | Details |
| 2/13/2026 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
23.00 (N/A) |
5.56 (7.18) |
29.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
